Skip to main content
Caplight Logo









BendBio

BendBio

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://bendbio.com/

Last Round

Growth Equity

Oct 11, 2022

Company Overview

BendBio is a biotechnology company that provides an inertial microfluidics platform for automated cell processing and cell therapy manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

inertial microfluidicscell therapy manufacturingautomated cell processingmicrofluidic modulesOEMcell sortingbiotech equipmentlabel-free cell separationcell concentrationbioprocessinglab-on-a-chipcell therapy toolsmicrofluidic enginebiotech hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BendBio Comparables

Compare BendBio with similar companies based on industry and business-model similarity.

BendBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MFX
79%
AcouSort AB
78%
Akadeum Life Sciences
77%

BendBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityOct 11, 2022

Key People

Founding team and executive leadership

Kyle Smith

CTO & Co-Founder

Founding Team

BendBio Investors

Notable investors and investment history

BendBio investors
InvestorRounds
QHP CapitalGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    Monthly visitors grew 156% MoM, reaching 764.

  • May 2, 2025

    Monthly visitors grew 405% MoM, reaching 1K.

BendBio Filings

Explore SEC and related filing metadata, where available.

BendBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BendBio's valuation, stock price, and market status.

Is BendBio a public or private company?

BendBio is a private company.

What is the current stock price of BendBio?

BendBio is a private company with no public stock price. No recent secondary market data is available.

How much is BendBio worth (valuation)?

Valuation information for BendBio is not publicly available.

Can I buy BendBio stock?

BendBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BendBio's last funding round?

BendBio's most recent funding round was Growth Equity on October 11, 2022.

Who are the main investors in BendBio?

Key investors in BendBio include QHP Capital.

Will BendBio IPO soon?

No public IPO plans have been announced for BendBio.

How can I track BendBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BendBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range2
Year Founded2021
Last FundingOct 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?